New drug combo tested for rare head and neck cancers
NCT ID NCT07464366
Summary
This study is testing whether an experimental drug called MRG003 works better alone or combined with another drug called putrelimab for people with advanced salivary gland cancer that has returned or spread. The trial will enroll 68 adults whose cancer has worsened despite previous treatments. Researchers will measure how well the treatments shrink tumors and control the cancer's growth over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SALIVARY GLAND CARCINOMAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.